This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of René Bartz
Introduction
René Bartz is a notable inventor based in Lawrenceville, NJ (US). He has made significant contributions to the field of chemical entities and oligonucleotide delivery methods. His work is recognized for its potential applications in various scientific and medical fields.
Latest Patents
René Bartz holds a patent for "Single chemical entities and methods for delivery of oligonucleotides." This invention discloses a modular composition that includes an oligonucleotide, one or more linkers, and one or more peptides. The linkers can be attached to the oligonucleotide at any 3' and/or 5' end. Additionally, the composition may include lipids, solubilizing groups, and/or targeting ligands attached to the oligonucleotide. This innovative approach enhances the delivery and efficacy of oligonucleotides in therapeutic applications.
Career Highlights
Bartz is currently associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. His role at Merck has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His expertise in chemical entities and oligonucleotide delivery has positioned him as a valuable asset in his field.
Collaborations
René Bartz has collaborated with esteemed colleagues such as Jeffrey G Aaronson and Stanley F Barnett. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of scientific knowledge.
Conclusion
René Bartz's contributions to the field of oligonucleotide delivery and chemical entities exemplify the impact of innovative thinking in science and medicine. His patent and work at Merck Sharp & Dohme Corporation highlight the importance of collaboration and creativity in driving advancements in healthcare.